Teleios Health review
Teleios Health advertises continuing support, but its exact monitoring schedule and narrow refund window need attention before treatment starts.
The verdict
The two named weekly injection options and separated platform, clinician and pharmacy roles are useful. Confirm the actual medical team, follow-up cadence and prescription-specific total rather than relying on a generic starting offer.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Teleios Health is a technology platform connecting patients with independent healthcare providers and pharmacies. It explicitly says the platform itself does not diagnose or treat patients.
Who writes the prescription, and what do they see?
A provider-patient relationship begins only after mutual acceptance with an independent clinician. Ask who is assigned, how that clinician is licensed for your location and which practice manages questions after the first review.
The homepage describes clinical review, pharmacy fulfillment and regular check-ins. It also advertises continuous support, but does not define a guaranteed clinical response time. Establish how scheduled reviews and between-visit concerns are handled.
What happens when the dose goes up?
Weekly compounded semaglutide and tirzepatide injections are listed. The clinician should set the regimen and any adjustments; the homepage’s general progress timeline is not an individualized prediction or dosing instruction.
What the price includes
The terms divide the professional fee into provider and partner-pharmacy components. Both treatment cards have starting prices, but a full quote needs the actual prescription and supply period. The service does not participate in insurance, Medicare or Medicaid networks.
What it claims, and what it cites
The named offers are compounded semaglutide and tirzepatide injections. The site states these are not FDA-approved. Results cited from studies of GLP-1 medicines should not be taken as proof of an equivalent result with a particular dispensed compound.
Where it holds up, and where it does not
- Strength: Names both compounded weekly injection options
- Strength: Explains that care comes from independent providers
- Limitation: Clinical follow-up frequency needs clarification
- Limitation: Treatment quotes require prescription-specific detail
What the evidence says about this kind of treatment
The assessment above is about Teleios Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Adults comfortable with independent online care who will confirm the clinician, pharmacy and monitoring arrangements.
- Wrong for
- Anyone needing guaranteed refunds after dispensing or assuming a marketing progress timeline predicts their response.
The evidence behind what Teleios Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Teleios Health compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: PeterMDSesame CareSnagRxSprout HealthStrut HealthWellorithm
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Who provides the medical care?
- Independent healthcare providers, not Teleios Health itself. Confirm the treating practice and clinician before beginning treatment.
- Does the homepage timeline predict my result?
- No. The published sequence is general marketing. Your clinician should discuss realistic expectations and review your individual response.
Sources for this review
Provider information checked . Terms can change.